Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,312,320,489
+$145,420,603 QoQ
Shares Held
28,792,064
-1.8% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#10
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 10%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. JNJ ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,312,320,489 | 28,792,064 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $7,166,899,886 | 29,319,669 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $6,059,792,553 | 29,281,433 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,557,510,403 | 29,972,551 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,633,372,007 | 30,333,041 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,131,723,102 | 30,943,820 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,456,201,363 | 30,813,175 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,448,537,273 | 27,449,940 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $4,155,330,113 | 28,430,009 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $4,529,342,902 | 28,632,296 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,659,958,881 | 29,730,502 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,724,381,724 | 30,333,109 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,156,425,687 | 31,152,886 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,188,570,285 | 33,474,647 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,963,168,394 | 33,756,968 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,509,828,948 | 33,728,140 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,010,382,625 | 33,859,403 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,035,523,163 | 34,054,749 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,871,740,302 | 34,323,612 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,646,667,749 | 34,963,887 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,179,179,310 | 31,438,505 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,268,739,036 | 32,058,041 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $5,148,691,891 | 32,715,033 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,015,172,423 | 33,686,005 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,777,593,736 | 33,972,792 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $4,404,153,289 | 33,586,161 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||